These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7281026)

  • 21. [Hemosorption as a treatment method for uremic complications].
    Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
    Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical results of charcoal hemoperfusion: studies of 55 cases extending over 250 incidents].
    Agishi T; Yamashita N; Ota K
    Nihon Rinsho; 1980 Dec; 38(12):4697-702. PubMed ID: 7253246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of hemosorption on uremic polyneuropathy].
    Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
    Urol Nefrol (Mosk); 1981; (1):59-61. PubMed ID: 6259797
    [No Abstract]   [Full Text] [Related]  

  • 24. Preliminary report on the efficiency of combined haemodialysis-haemoperfusion treatment in chronic uraemia.
    Albertazzi A; Cappelli P; Di Paolo B; Evangelista M
    Life Support Syst; 1984; 2(4):245-51. PubMed ID: 6527556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activated charcoal surface ultrastructure after haemoperfusion (author's transl)].
    Bucek J; Mydlík M
    Cas Lek Cesk; 1980 Nov; 119(45):1205-7. PubMed ID: 7438181
    [No Abstract]   [Full Text] [Related]  

  • 26. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
    Kon'kova TA; Chudnovskaia MV; Golovanov SA
    Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption].
    Iakovlev VP; Skala LZ; Cherniakov VL; Shcherbakov VA; Shuster AM
    Antibiot Med Biotekhnol; 1985 May; 30(5):380-3. PubMed ID: 4026260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine clinical applications of hemodialysis-hemoperfusion in chronic renal failure: case reports.
    Barré PE; Gonda A; Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):305-8. PubMed ID: 3023242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Developing trends in the active therapy of kidney failure. Hemodialysis--hemofiltration--hemoperfusion].
    Klinkmann H; Kolff WJ
    Z Gesamte Inn Med; 1978 Jun; 33(11):351-5. PubMed ID: 685330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The morphological characteristics of the erythrocytes during hemosorption in patients with chronic kidney failure and suppurative intoxication].
    Samoĭlov MV; Danilkov AP; Kudriavtsev IuV; Naumov AG
    Urol Nefrol (Mosk); 1993; (1):34-7. PubMed ID: 7941124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Function of the blood prekallikrein-kallikrein system of patients with terminal kidney failure as affected by hemosorption].
    Petrun' NM; Baran EIa; Krimkevich EI
    Urol Nefrol (Mosk); 1986; (6):41-4. PubMed ID: 2433828
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
    Liu J; Liu ZQ; Tao HQ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetics of cefazolin during hemosorption and hemodialysis].
    Firsov AA; Treskina OS; Nasonov VN; Umnova LV; Cherniakov VL
    Antibiot Med Biotekhnol; 1986 Nov; 31(11):871-4. PubMed ID: 3813510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoperfusion for uremia: past, present, and future.
    Winchester JF; Ash SR
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.
    Shieh S; Cohen JL; Lim HW
    J Am Acad Dermatol; 2000 Apr; 42(4):645-52. PubMed ID: 10727312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodialysis and hemoperfusion in a patient with an isolated phenytoin overdose.
    Miller MA; Crystal CS; Patel MM
    Am J Emerg Med; 2006 Oct; 24(6):748-9. PubMed ID: 16984852
    [No Abstract]   [Full Text] [Related]  

  • 37. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
    Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The problems concerning experimental research and clinical application of dialysis therapy and blood perfusion with activated charcoal (author's transl)].
    Zhonghua Nei Ke Za Zhi; 1982 Jan; 21(1):51-4. PubMed ID: 7075370
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of hemodialysis on neutrophil enzyme activity in patients with uremia].
    Moshchin'skiĭ P; Sydor A; Slovin'ski S
    Lab Delo; 1991; (2):21-3. PubMed ID: 1709978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.